検索結果 - Duncan I. Jodrell

結果の絞り込み
  1. 1
    Anti-Tumour Effects of a Specific Anti-ADAM17 Antibody in an Ovarian Cancer Model In Vivo

    Anti-Tumour Effects of a Specific Anti-ADAM17 Antibody in an Ovarian Cancer Model In Vivo 著者: Frances M. Richards, Christopher J. Tape, Duncan I. Jodrell, Gillian Murphy

    出版事項 2012
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  2. 2
    GEMMs as preclinical models for testing pancreatic cancer therapies

    GEMMs as preclinical models for testing pancreatic cancer therapies 著者: Aarthi Gopinathan, Jennifer P. Morton, Duncan I. Jodrell, Owen J. Sansom

    出版事項 2015
    全文の入手
    Revisão
    お気に入りに追加
    保存先:
  3. 3
    Targeting of 5-aza-2′-deoxycytidine residues by chromatin-associated DNMT1 induces proteasomal degradation of the free enzyme

    Targeting of 5-aza-2′-deoxycytidine residues by chromatin-associated DNMT1 induces proteasomal degradation of the free enzyme 著者: Katan I. Patel, Jacqueline Dickson, Shikuan Din, Kenneth M. MacLeod, Duncan I. Jodrell, Bernard Ramsahoye

    出版事項 2010
    全文の入手
    Artigo
    お気に入りに追加
    保存先:
  4. 4
    Enhanced oxaliplatin-induced apoptosis following antisense Bcl-xl down-regulation is p53 and Bax dependent: Genetic evidence for specificity of the antisense effect

    Enhanced oxaliplatin-induced apoptosis following antisense Bcl-xl down-regulation is p53 and Bax dependent: Genetic evidence for specificity of the antisense effect 著者: Richard L. Hayward, Janet S. Macpherson, Jeff Cummings, Brett P. Monia, John F. Smyth, Duncan I. Jodrell

    出版事項 2004
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  5. 5
    A quantitative FastFUCCI assay defines cell cycle dynamics at a single-cell level

    A quantitative FastFUCCI assay defines cell cycle dynamics at a single-cell level 著者: Siang‐Boon Koh, Patrice Mascalchi, Esther Rodríguez, Yao Lin, Duncan I. Jodrell, Frances M. Richards, Scott K. Lyons

    出版事項 2016
    全文の入手
    Artigo
    お気に入りに追加
    保存先:
  6. 6
    <i>nab</i>-Paclitaxel Potentiates Gemcitabine Activity by Reducing Cytidine Deaminase Levels in a Mouse Model of Pancreatic Cancer

    <i>nab</i>-Paclitaxel Potentiates Gemcitabine Activity by Reducing Cytidine Deaminase Levels in a Mouse Model of Pancreatic Cancer 著者: Kristopher K. Frese, Albrecht Neeße, Natalie Cook, Tashinga E. Bapiro, Martijn P. Lolkema, Duncan I. Jodrell, David A. Tuveson

    出版事項 2012
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  7. 7
    Optimization of the Antitumor Activity of Sequence-specific Pyrrolobenzodiazepine Derivatives Based on their Affinity for ABC Transporters

    Optimization of the Antitumor Activity of Sequence-specific Pyrrolobenzodiazepine Derivatives Based on their Affinity for ABC Transporters 著者: Maciej Kaliszczak, Dyeison Antonow, Katan I. Patel, Philip W. Howard, Duncan I. Jodrell, David E. Thurston, Sylvie M. Guichard

    出版事項 2010
    全文の入手
    Artigo
    お気に入りに追加
    保存先:
  8. 8
    In vitro and in vivo activity and cross resistance profiles of novel ruthenium (II) organometallic arene complexes in human ovarian cancer

    In vitro and in vivo activity and cross resistance profiles of novel ruthenium (II) organometallic arene complexes in human ovarian cancer 著者: Rhona Aird, Jeffrey L. Cummings, Alison Ritchie, Morwenna Muir, Robert E. Morris, H Chen, Peter J. Sadler, Duncan I. Jodrell

    出版事項 2002
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  9. 9
    Tumor-Induced IL-6 Reprograms Host Metabolism to Suppress Anti-tumor Immunity

    Tumor-Induced IL-6 Reprograms Host Metabolism to Suppress Anti-tumor Immunity 著者: Thomas R. Flint, Tobias Janowitz, Claire M. Connell, Edward W. Roberts, Alice E. Denton, Anthony P. Coll, Duncan I. Jodrell, Douglas T. Fearon

    出版事項 2016
    全文の入手
    Artigo
    お気に入りに追加
    保存先:
  10. 10
    Mechanistic Distinctions between CHK1 and WEE1 Inhibition Guide the Scheduling of Triple Therapy with Gemcitabine

    Mechanistic Distinctions between CHK1 and WEE1 Inhibition Guide the Scheduling of Triple Therapy with Gemcitabine 著者: Siang‐Boon Koh, Yann Wallez, Charles R. Dunlop, Sandra Bernaldo de Quirós Fernández, Tashinga E. Bapiro, Frances M. Richards, Duncan I. Jodrell

    出版事項 2018
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  11. 11
    γ-H2AX Foci Formation as a Pharmacodynamic Marker of DNA Damage Produced by DNA Cross-Linking Agents: Results from 2 Phase I Clinical Trials of SJG-136 (SG2000)

    γ-H2AX Foci Formation as a Pharmacodynamic Marker of DNA Damage Produced by DNA Cross-Linking Agents: Results from 2 Phase I Clinical Trials of SJG-136 (SG2000) 著者: Jenny Wu, Peter H. Clingen, Victoria J. Spanswick, Maria Mellinas‐Gomez, Tim Meyer, Igor Puzanov, Duncan I. Jodrell, Daniel Hochhauser, John A. Hartley

    出版事項 2012
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  12. 12
    SPARC independent drug delivery and antitumour effects of<i>nab</i>-paclitaxel in genetically engineered mice

    SPARC independent drug delivery and antitumour effects of<i>nab</i>-paclitaxel in genetically engineered mice 著者: Albrecht Neeße, Kristopher K. Frese, Derek Chan, Tashinga E. Bapiro, William Howat, Frances M. Richards, Volker Ellenrieder, Duncan I. Jodrell, David A. Tuveson

    出版事項 2013
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  13. 13
    A Phase 1 Study of AS1409, a Novel Antibody-Cytokine Fusion Protein, in Patients with Malignant Melanoma or Renal Cell Carcinoma

    A Phase 1 Study of AS1409, a Novel Antibody-Cytokine Fusion Protein, in Patients with Malignant Melanoma or Renal Cell Carcinoma 著者: Sarah Maria Rudman, Michael B. Jameson, Mark J. McKeage, Philip Savage, Duncan I. Jodrell, Mark Harries, Gary D Acton, Fredrik Erlandsson, James Spicer

    出版事項 2011
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  14. 14
    CTGF antagonism with mAb FG-3019 enhances chemotherapy response without increasing drug delivery in murine ductal pancreas cancer

    CTGF antagonism with mAb FG-3019 enhances chemotherapy response without increasing drug delivery in murine ductal pancreas cancer 著者: Albrecht Neeße, Kristopher K. Frese, Tashinga E. Bapiro, Tomoaki Nakagawa, Mark D. Sternlicht, Todd Seeley, Christian Pilarsky, Duncan I. Jodrell, Suzanne Spong, David A. Tuveson

    出版事項 2013
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  15. 15
    Aspirin activates the NF- B signalling pathway and induces apoptosis in intestinal neoplasia in two in vivo models of human colorectal cancer

    Aspirin activates the NF- B signalling pathway and induces apoptosis in intestinal neoplasia in two in vivo models of human colorectal cancer 著者: Lesley A. Stark, Kenneth GC Reid, Owen J. Sansom, Farhat Din, Sylvie M. Guichard, I. Mayer, Duncan I. Jodrell, Alan R. Clarke, Malcolm G. Dunlop

    出版事項 2006
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  16. 16
    Complete loss of ATM function augments replication catastrophe induced by ATR inhibition and gemcitabine in pancreatic cancer models

    Complete loss of ATM function augments replication catastrophe induced by ATR inhibition and gemcitabine in pancreatic cancer models 著者: Charles R. Dunlop, Yann Wallez, Timothy Isaac Johnson, Sandra Bernaldo de Quirós Fernández, Stephen T. Durant, Elaine Cadogan, Alan Lau, Frances M. Richards, Duncan I. Jodrell

    出版事項 2020
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  17. 17
    A randomised comparison between 6 months of bolus fluorouracil/leucovorin and 12 weeks of protracted venous infusion fluorouracil as adjuvant treatment in colorectal cancer

    A randomised comparison between 6 months of bolus fluorouracil/leucovorin and 12 weeks of protracted venous infusion fluorouracil as adjuvant treatment in colorectal cancer 著者: Ian Chau, A. Norman, David Cunningham, Diana Tait, Paul J. Ross, Timothy Iveson, Mark Hill, Tamas Hickish, F. Lofts, Duncan I. Jodrell, Andrew Webb, J. Oates

    出版事項 2005
    全文の入手
    Artigo
    お気に入りに追加
    保存先:
  18. 18
    Twelve weeks of protracted venous infusion of fluorouracil (5-FU) is as effective as 6 months of bolus 5-FU and folinic acid as adjuvant treatment in colorectal cancer

    Twelve weeks of protracted venous infusion of fluorouracil (5-FU) is as effective as 6 months of bolus 5-FU and folinic acid as adjuvant treatment in colorectal cancer 著者: Andrea Saini, A. Norman, David Cunningham, Ian Chau, Mark Hill, Diana Tait, Tamas Hickish, Timothy Iveson, F. Lofts, Duncan I. Jodrell, Paul J. Ross, J. Oates

    出版事項 2003
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  19. 19
    Depletion of Macrophages Improves Therapeutic Response to Gemcitabine in Murine Pancreas Cancer

    Depletion of Macrophages Improves Therapeutic Response to Gemcitabine in Murine Pancreas Cancer 著者: S Buchholz, Robert G. Goetze, Shiv K. Singh, Christoph Ammer‐Herrmenau, Frances M. Richards, Duncan I. Jodrell, Malte Buchholz, Patrick Michl, Volker Ellenrieder, Elisabeth Heßmann, Albrecht Neeße

    出版事項 2020
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  20. 20
    Gamma secretase inhibition promotes hypoxic necrosis in mouse pancreatic ductal adenocarcinoma

    Gamma secretase inhibition promotes hypoxic necrosis in mouse pancreatic ductal adenocarcinoma 著者: Natalie Cook, Kristopher K. Frese, Tashinga E. Bapiro, Michael A. Jacobetz, Aarthi Gopinathan, Jodi L. Miller, Sudhir Rao, Tim Demuth, William Howat, Duncan I. Jodrell, David A. Tuveson

    出版事項 2012
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:

検索ツール: